Matthew P. Blischak - May 16, 2023 Form 3 Insider Report for Finch Therapeutics Group, Inc. (FNCH)

Role
Chief Executive Officer
Signature
/s/ Matthew P. Blischak
Stock symbol
FNCH
Transactions as of
May 16, 2023
Transactions value $
$0
Form type
3
Date filed
5/16/2023, 04:17 PM
Next filing
Jun 9, 2023

No securities are beneficially owned.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney